Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
RGS3
Introduction
Regulator of G-protein signaling 3 is a protein that in humans is encoded by the RGS3 gene.[1][2][3]
This gene encodes a member of the regulator of G-protein signaling (RGS) family. This protein is a GTP-ase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. Multiple alternatively spliced transcript variants have been described for this gene but the full-length nature of some transcripts is not yet known.[3]
References
References
- β Druey KM, Blumer KJ, Kang VH, Kehrl JH (May 1996). “Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family”. Nature. 379 (6567): 742β6. doi:10.1038/379742a0. PMIDΒ 8602223.
- β Linares JL, Wendling C, Tomasetto C, Rio MC (Nov 2000). “C2PA, a new protein expressed during mouse spermatogenesis”. FEBS Lett. 480 (2β3): 249β54. doi:10.1016/S0014-5793(00)01942-6. PMIDΒ 11034339.
- β 3.0 3.1 “Entrez Gene: RGS3 regulator of G-protein signalling 3”.
Further reading
Further reading
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1β2): 171β4. doi:10.1016/0378-1119(94)90802-8. PMIDΒ 8125298.
- Chatterjee TK, Eapen A, Kanis AB, Fisher RA (1998). “Genomic organization, 5′-flanking region, and chromosomal localization of the human RGS3 gene”. Genomics. 45 (2): 429β33. doi:10.1006/geno.1997.4929. PMIDΒ 9344672.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1β2): 149β56. doi:10.1016/S0378-1119(97)00411-3. PMIDΒ 9373149.
- Dulin NO, Sorokin A, Reed E, et al. (1999). “RGS3 Inhibits G Protein-Mediated Signaling via Translocation to the Membrane and Binding to GΞ±11”. Mol. Cell. Biol. 19 (1): 714β23. PMCΒ 83928. PMIDΒ 9858594.
- Dulin NO, Pratt P, Tiruppathi C, et al. (2000). “Regulator of G protein signaling RGS3T is localized to the nucleus and induces apoptosis”. J. Biol. Chem. 275 (28): 21317β23. doi:10.1074/jbc.M910079199. PMIDΒ 10749886.
- Shi CS, Lee SB, Sinnarajah S, et al. (2001). “Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation”. J. Biol. Chem. 276 (26): 24293β300. doi:10.1074/jbc.M100089200. PMIDΒ 11294858.
- Lu Q, Sun EE, Klein RS, Flanagan JG (2001). “Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction”. Cell. 105 (1): 69β79. doi:10.1016/S0092-8674(01)00297-5. PMIDΒ 11301003.
- Mittmann C, SchΓΌler C, Chung CH, et al. (2001). “Evidence for a short form of RGS3 preferentially expressed in the human heart”. Naunyn Schmiedebergs Arch. Pharmacol. 363 (4): 456β63. doi:10.1007/s002100000376. PMIDΒ 11330340.
- Niu J, Scheschonka A, Druey KM, et al. (2002). “RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain”. Biochem. J. 365 (Pt 3): 677β84. doi:10.1042/BJ20020390. PMCΒ 1222729. PMIDΒ 11985497.
- Kehrl JH, Srikumar D, Harrison K, et al. (2002). “Additional 5′ exons in the RGS3 locus generate multiple mRNA transcripts, one of which accounts for the origin of human PDZ-RGS3”. Genomics. 79 (6): 860β8. doi:10.1006/geno.2002.6773. PMIDΒ 12036301.
- Ikeda M, Okai M, Miyoshi T, et al. (2003). “Transcriptional suppression of the estrogen receptor by truncated estrogen receptor-alpha”. Horm. Metab. Res. 34 (8): 425β30. doi:10.1055/s-2002-33599. PMIDΒ 12198596.
- Hirabayashi S, Ohno H, Iida J, Hata Y (2003). “C2PA is a nuclear protein implicated in the heat shock response”. J. Cell. Biochem. 87 (1): 65β74. doi:10.1002/jcb.10279. PMIDΒ 12210723.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899β903. doi:10.1073/pnas.242603899. PMCΒ 139241. PMIDΒ 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40β5. doi:10.1038/ng1285. PMIDΒ 14702039.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). “DNA sequence and analysis of human chromosome 9”. Nature. 429 (6990): 369β74. doi:10.1038/nature02465. PMCΒ 2734081. PMIDΒ 15164053.
- Tovey SC, Willars GB (2005). “Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor”. Mol. Pharmacol. 66 (6): 1453β64. doi:10.1124/mol.104.005827. PMIDΒ 15383626.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121β7. doi:10.1101/gr.2596504. PMCΒ 528928. PMIDΒ 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173β8. doi:10.1038/nature04209. PMIDΒ 16189514.